Alam Kamran
- SEC CIK
- 0001793412
In the past year, 2 open-market sale filings worth $492.5K and no purchases.
Current role at each company
- TSHA Taysha Gene Therapies, Inc.CHIEF FINANCIAL OFFICERas of Feb 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $492.5K
- 2 filings
- Net
- −$492.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Alam Kamran as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 (view filing) | Feb 4 | 2 days | Alam KamranCHIEF FINANCIAL OFFICER | SSale | −1.66K | $4.52 | −$7.48K | −0.1%1.44M after | |
| Jan 27, 2026 (view filing) | Jan 23-26 | 4 days | Alam KamranCHIEF FINANCIAL OFFICER | SSale | −102.8K | $4.72 | −$485.0K | −6.6%1.44M after | 2 lots |
| Aug 22, 2025 (view filing) | Aug 21 | 1 day | Alam KamranCHIEF FINANCIAL OFFICER | SSale | −54.5K | $2.85 | −$155.3K | −4.4%1.19M after | |
| Aug 25, 2023 (view filing) | Aug 24 | 1 day | Alam KamranChief Financial Officer | SSale | −33.0K | $2.33 | −$76.9K | −11.3%258.0K after | 10b5-1 |
| Aug 24, 2022 (view filing) | Aug 23 | 1 day | Alam KamranChief Financial Officer | SSale | −3.33K | $3.47 | −$11.5K | −1.2%266.1K after | |
| Aug 22, 2022 (view filing) | Aug 18-22 | 4 days | Alam KamranChief Financial Officer | SSale | −28.7K | $3.70 | −$106.0K | −9.6%269.4K after | 3 lots |
| Aug 20, 2021 (view filing) | Aug 18-20 | 2 days | Alam KamranChief Financial Officer | SSale | −33.0K | $16.88 | −$557.0K | −10.0%298.1K after | 5 lots |